5-Amino-1MQ is a small molecule inhibitor of nicotinamide N-methyltransferase, an enzyme highly expressed in adipose tissue that regulates NAD+ metabolism and cellular energy balance. Research demonstrates inhibition of…
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist developed originally as an antidiabetic agent. Clinical trials demonstrated significant reductions in body weight and improvements in glycaemic…
AOD-9604 is a modified fragment of human growth hormone consisting of amino acids 176 to 191 with an additional tyrosine at the N-terminus. Research focuses on stimulation of…
Retatrutide is a triple GIP, GLP-1, and glucagon receptor agonist, the first in this class to enter clinical investigation. Phase 2 trials showed up to 24 percent body…
Semaglutide is a GLP-1 receptor agonist with a 94% structural homology to human GLP-1. Half-life of approximately 7 days due to albumin binding and protease resistance modifications. Research…
Tirzepatide is a novel dual GIP and GLP-1 receptor agonist developed originally as an antidiabetic agent. Clinical trials demonstrated significant reductions in body weight and improvements in glycaemic…
PT-141, also known as Bremelanotide, is a cyclic heptapeptide melanocortin receptor agonist derived from Melanotan II by removal of the C-terminal amide group. Research continues on MC3R and…
GHK-Cu is a naturally occurring copper complex isolated from human plasma that decreases with age. Research documents broad biological activity including upregulation of collagen and glycosaminoglycan synthesis, antioxidant…
Melanotan II is a synthetic analogue of alpha-MSH with a cyclic lactam structure. Research applications include MC1R and MC4R receptor pharmacology, skin pigmentation mechanisms, appetite regulation, and sexual…
PE-22-28 is a synthetic analogue of Spadin, a peptide derived from the propeptide of neurotensin receptor 3. Research focuses on TREK-1 potassium channel blockade as a rapid-onset antidepressant…